It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Study design
Randomised double-blind factorial-design placebo-controlled trial.
Objective
Urinary tract infections (UTIs) are common in people with spinal cord injury (SCI). UTIs are increasingly difficult to treat due to emergence of multi-resistant organisms. Probiotics are efficacious in preventing UTIs in post-menopausal women. We aimed to determine whether probiotic therapy with Lactobacillus reuteri RC-14+Lactobacillus GR-1 (RC14-GR1) and/or Lactobacillus rhamnosus GG+Bifidobacterium BB-12 (LGG-BB12) are effective in preventing UTI in people with SCI.
Setting
Spinal units in New South Wales, Australia with their rural affiliations.
Methods
We recruited 207 eligible participants with SCI and stable neurogenic bladder management. They were randomised to one of four arms: RC14-GR1+LGG-BB12, RC14-GR1+placebo, LGG-BB12+ placebo or double placebos for 6 months. Randomisation was stratified by bladder management type and inpatient or outpatient status. The primary outcome was time to occurrence of symptomatic UTI.
Results
Analysis was based on intention to treat. Participants randomised to RC14-GR1 had a similar risk of UTI as those not on RC14-GR1 (HR 0.67; 95% CI: 0.39–1.18; P = 0.17) after allowing for pre-specified covariates. Participants randomised to LGG-BB12 also had a similar risk of UTI as those not on LGG-BB12 (HR 1.29; 95% CI: 0.74–2.25; P = 0.37). Multivariable post hoc survival analysis for RC14-GR1 only vs. the other three groups showed a potential protective effect (HR 0.46; 95% CI: 0.21–0.99; P = 0.03), but this result would need to be confirmed before clinical application.
Conclusion
In this RCT, there was no effect of RC14-GR1 or LGG-BB12 in preventing UTI in people with SCI.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Prince of Wales Hospital, Department of Spinal and Rehabilitation Medicine, Sydney, Australia (GRID:grid.415193.b); University of Sydney, School of Public Health, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X)
2 Prince of Wales Hospital, Department of Spinal and Rehabilitation Medicine, Sydney, Australia (GRID:grid.415193.b); Neuroscience Research Australia [NeuRA] and the University of New South Wales, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
3 Neuroscience Research Australia [NeuRA] and the University of New South Wales, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
4 University of Sydney, School of Public Health, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X)
5 Prince of Wales Hospital, Department of Infectious Diseases, Sydney, Australia (GRID:grid.415193.b)
6 Neuroscience Research Australia [NeuRA] and the University of New South Wales, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432); University of New South Wales, Centre for Marine Bio-Innovation, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432)
7 University of New South Wales, Centre for Marine Bio-Innovation, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432); Nanyang Technological University, The Singapore Centre for Life Sciences Engineering and the School of Biological Sciences, Singapore, Singapore (GRID:grid.59025.3b) (ISNI:0000 0001 2224 0361)
8 Royal Rehabilitation Centre Sydney, Sydney, Australia (GRID:grid.419366.f) (ISNI:0000 0004 0613 2733)
9 Royal North Shore Hospital, Sydney, Australia (GRID:grid.412703.3) (ISNI:0000 0004 0587 9093)
10 University of Technology Sydney, Centre for Health Economics Research and Evaluation [CHERE], Sydney, Australia (GRID:grid.117476.2) (ISNI:0000 0004 1936 7611)
11 Kolling Institute, John Walsh Centre for Rehabilitation Research, St Leonards, Australia (GRID:grid.117476.2); University of Sydney, Sydney Medical School Northern, Sydney, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X)